Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-13 Sale | 2023-02-15 4:30 pm | Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | 2,790 | $9.6653 | $26,966 | 65,559 (Direct) | View |
| 2022-06-15 Sale | 2022-06-16 4:15 pm | Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | 5,145 | $10.06 | $51,745 | 68,349 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-10 Option Award | 2022-02-11 4:21 pm | N/A 2032-02-09 | Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | 125,107 | $0 | 166,892 (Direct) | View |
| 2021-12-22 Option Award | 2021-12-23 4:10 pm | N/A N/A | Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer | 9,084 | $0 | 41,785 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-16 4:19 pm | N/A 2031-06-13 | Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer | 85,419 | $0 | 85,419 (Direct) | View |
Ownership | 2021-06-16 4:18 pm | N/A N/A | Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer | 0 | $0 | 0 (Direct) | View |
| 2020-08-15 Tax Withholding | 2020-08-18 6:15 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Shearman Mark S Chief Scientific Officer | 5,723 | $5.77 | 33,277 (Direct) | View |
| 2020-08-05 Option Award | 2020-08-07 8:07 pm | N/A 2030-08-05 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Shearman Mark S Chief Scientific Officer | 50,000 | $0 | 50,000 (Direct) | View |